Lysosomal dysfunction as an inhibitor of vitamin B12 utilisation in neurodegenerative diseases

Website
http://purl.org/au-research/grants/nhmrc/1065982

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.

Funded Activity Summary

Vitamin B12 is required for red blood cell formation, DNA synthesis and normal neurological function. B12 deficiency contributes to age-related cognitive decline and Alzheimer’s disease. This research will provide important new information regarding the ageing process and the impact that brain changes associated with ageing and Alzheimer's disease have on B12 metabolism. It will provide important information related to the therapeutic potential of B12.

Funded Activity Details

Start Date: 2014

End Date: 2016

Funding Scheme: Project Grants

Funding Amount: $554,901.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Related Researchers

No related researchers have been discovered for grant Lysosomal dysfunction as an inhibitor of vitamin B12 utilisation in neurodegenerative diseases.

Related Organisations

No related organisations have been discovered for grant Lysosomal dysfunction as an inhibitor of vitamin B12 utilisation in neurodegenerative diseases.